{
  "ConceptSets": [
    {
      "id": 1,
      "name": "VAX_AZ",
      "expression": {
        "items": [
          {
            "concept": {
              "CONCEPT_CLASS_ID": "11-digit NDC",
              "CONCEPT_CODE": "00310122210",
              "CONCEPT_ID": 1230962,
              "CONCEPT_NAME": "AZD1222 Astrazeneca COVID-19 vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x1010 viral particles/0.5mL dosage, for intramuscular use",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "N",
              "STANDARD_CONCEPT_CAPTION": "Non-Standard",
              "VOCABULARY_ID": "NDC"
            },
            "includeDescendants": true
          },
          {
            "concept": {
              "CONCEPT_CLASS_ID": "CVX",
              "CONCEPT_CODE": "210",
              "CONCEPT_ID": 724905,
              "CONCEPT_NAME": "SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "S",
              "STANDARD_CONCEPT_CAPTION": "Standard",
              "VOCABULARY_ID": "CVX"
            },
            "includeDescendants": true
          },
          {
            "concept": {
              "CONCEPT_CLASS_ID": "CPT4",
              "CONCEPT_CODE": "0021A",
              "CONCEPT_ID": 766236,
              "CONCEPT_NAME": "AstraZeneca Covid-19 Vaccine Administration - First Dose",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "N",
              "STANDARD_CONCEPT_CAPTION": "Non-Standard",
              "VOCABULARY_ID": "CPT4"
            },
            "includeDescendants": true
          },
          {
            "concept": {
              "CONCEPT_CLASS_ID": "CPT4",
              "CONCEPT_CODE": "0022A",
              "CONCEPT_ID": 766237,
              "CONCEPT_NAME": "AstraZeneca Covid-19 Vaccine Administration - Second Dose",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "N",
              "STANDARD_CONCEPT_CAPTION": "Non-Standard",
              "VOCABULARY_ID": "CPT4"
            },
            "includeDescendants": true
          },
          {
            "concept": {
              "CONCEPT_CLASS_ID": "CPT4",
              "CONCEPT_CODE": "91302",
              "CONCEPT_ID": 766240,
              "CONCEPT_NAME": "AstraZeneca Covid-19 Vaccine",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "N",
              "STANDARD_CONCEPT_CAPTION": "Non-Standard",
              "VOCABULARY_ID": "CPT4"
            },
            "includeDescendants": true
          },
          {
            "concept": {
              "CONCEPT_CLASS_ID": "AMP",
              "CONCEPT_CODE": "39114911000001105",
              "CONCEPT_ID": 35891522,
              "CONCEPT_NAME": "COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "N",
              "STANDARD_CONCEPT_CAPTION": "Non-Standard",
              "VOCABULARY_ID": "dm+d"
            },
            "includeDescendants": true
          },
          {
            "concept": {
              "CONCEPT_CLASS_ID": "AMPP",
              "CONCEPT_CODE": "39301311000001102",
              "CONCEPT_ID": 35895099,
              "CONCEPT_NAME": "COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca UK Ltd) 100 dose 10 x 10 dose vials",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "N",
              "STANDARD_CONCEPT_CAPTION": "Non-Standard",
              "VOCABULARY_ID": "dm+d"
            },
            "includeDescendants": true
          },
          {
            "concept": {
              "CONCEPT_CLASS_ID": "AMPP",
              "CONCEPT_CODE": "39115111000001106",
              "CONCEPT_ID": 35891864,
              "CONCEPT_NAME": "COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca UK Ltd) 10 dose",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "N",
              "STANDARD_CONCEPT_CAPTION": "Non-Standard",
              "VOCABULARY_ID": "dm+d"
            },
            "includeDescendants": true
          },
          {
            "concept": {
              "CONCEPT_CLASS_ID": "AMPP",
              "CONCEPT_CODE": "39301211000001105",
              "CONCEPT_ID": 35895100,
              "CONCEPT_NAME": "COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca UK Ltd) 80 dose 10 x 8 dose vials",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "N",
              "STANDARD_CONCEPT_CAPTION": "Non-Standard",
              "VOCABULARY_ID": "dm+d"
            },
            "includeDescendants": true
          },
          {
            "concept": {
              "CONCEPT_CLASS_ID": "AMPP",
              "CONCEPT_CODE": "39115011000001105",
              "CONCEPT_ID": 35891906,
              "CONCEPT_NAME": "COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca UK Ltd) 8 dose",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "N",
              "STANDARD_CONCEPT_CAPTION": "Non-Standard",
              "VOCABULARY_ID": "dm+d"
            },
            "includeDescendants": true
          },
          {
            "concept": {
              "CONCEPT_CLASS_ID": "11-digit NDC",
              "CONCEPT_CODE": "00310122215",
              "CONCEPT_ID": 1227568,
              "CONCEPT_NAME": "azd1222 50000000000{VP}/.5mL INTRAMUSCULAR INJECTION, SUSPENSION",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "N",
              "STANDARD_CONCEPT_CAPTION": "Non-Standard",
              "VOCABULARY_ID": "NDC"
            },
            "includeDescendants": true
          },
          {
            "concept": {
              "CONCEPT_CLASS_ID": "VMP",
              "CONCEPT_CODE": "39116211000001106",
              "CONCEPT_ID": 35891649,
              "CONCEPT_NAME": "Generic COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "N",
              "STANDARD_CONCEPT_CAPTION": "Non-Standard",
              "VOCABULARY_ID": "dm+d"
            },
            "includeDescendants": true
          },
          {
            "concept": {
              "CONCEPT_CLASS_ID": "VMPP",
              "CONCEPT_CODE": "39301111000001104",
              "CONCEPT_ID": 35895193,
              "CONCEPT_NAME": "Generic COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials 100 dose",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "N",
              "STANDARD_CONCEPT_CAPTION": "Non-Standard",
              "VOCABULARY_ID": "dm+d"
            },
            "includeDescendants": true
          },
          {
            "concept": {
              "CONCEPT_CLASS_ID": "VMPP",
              "CONCEPT_CODE": "39114811000001100",
              "CONCEPT_ID": 35891890,
              "CONCEPT_NAME": "Generic COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials 10 dose",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "N",
              "STANDARD_CONCEPT_CAPTION": "Non-Standard",
              "VOCABULARY_ID": "dm+d"
            },
            "includeDescendants": true
          },
          {
            "concept": {
              "CONCEPT_CLASS_ID": "VMPP",
              "CONCEPT_CODE": "39301011000001100",
              "CONCEPT_ID": 35895194,
              "CONCEPT_NAME": "Generic COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials 80 dose",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "N",
              "STANDARD_CONCEPT_CAPTION": "Non-Standard",
              "VOCABULARY_ID": "dm+d"
            },
            "includeDescendants": true
          },
          {
            "concept": {
              "CONCEPT_CLASS_ID": "VMPP",
              "CONCEPT_CODE": "39114711000001108",
              "CONCEPT_ID": 35891433,
              "CONCEPT_NAME": "Generic COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials 8 dose",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "N",
              "STANDARD_CONCEPT_CAPTION": "Non-Standard",
              "VOCABULARY_ID": "dm+d"
            },
            "includeDescendants": true
          }
        ]
      }
    }
  ],
  "PrimaryCriteria": {
    "CriteriaList": [
      {
        "DrugExposure": {
          "CodesetId": 1
        }
      },
      {
        "DrugExposure": {
          "DrugSourceConcept": 1
        }
      }
    ],
    "ObservationWindow": {
      "PriorDays": 0,
      "PostDays": 0
    },
    "PrimaryCriteriaLimit": {
      "Type": "First"
    }
  },
  "QualifiedLimit": {
    "Type": "First"
  },
  "ExpressionLimit": {
    "Type": "First"
  },
  "InclusionRules": [
    {
      "name": "has at least 365d prior observation",
      "expression": {
        "Type": "ALL",
        "CriteriaList": [
          {
            "Criteria": {
              "ObservationPeriod": {}
            },
            "StartWindow": {
              "Start": {
                "Coeff": -1
              },
              "End": {
                "Days": 365,
                "Coeff": -1
              },
              "UseEventEnd": false
            },
            "EndWindow": {
              "Start": {
                "Days": 0,
                "Coeff": -1
              },
              "End": {
                "Coeff": 1
              },
              "UseEventEnd": true
            },
            "Occurrence": {
              "Type": 2,
              "Count": 1
            }
          }
        ],
        "DemographicCriteriaList": [],
        "Groups": []
      }
    }
  ],
  "EndStrategy": {
    "CustomEra": {
      "DrugCodesetId": 3,
      "GapDays": 112,
      "Offset": 0
    }
  },
  "CensoringCriteria": [],
  "CollapseSettings": {
    "CollapseType": "ERA",
    "EraPad": 0
  },
  "CensorWindow": {},
  "cdmVersionRange": ">=5.0.0"
}